In conclusion, RASSF10 is an important downstream target of RNF2 and the RASSF10/NPM/GADD45a/RNF2 feedback cascade may be used as a new biomarker for diagnosis and novel drug target for the therapy of gastric cancer. This evidence concerns the gene RASSF10 and gastric cancer.